Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Quarterly Basic Net EPS At 2016-02-29

0

For the year ended 2016-02-29 Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) basic consolidated EPS came $-0.6684. Conversely, for the quarter ended 2016-02-29, it was $-0.6684.

EPS can be simply called as a fraction of profits that is disbursed against each outstanding share. It is measured using the formula – net profit/outstanding shares. The element ‘Per-share earnings’ is majorly utilized by market experts to give earnings and price projections. Suppose a group “S” announces a net profit of $15,000 in a given year. The count of outstanding shares is 300. So, its EPS will be $50. EPS is issued every quarter, indicating the stakeholders can evaluate the financial performance periodically.

EPS alone cannot indicate on the financial well-being of a firm. For a clear picture, it is vital to look into the price to earnings ratio of company.

EPS from continuing operations

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) EPS from continuing operations was $-0.6684 for the fiscal ended 2016-02-29. For the quarter ended 2016-02-29, this figure was $-0.6684.

EPS contribution from parent

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) confirmed basic EPS of $-0.6684 for the year ended 2016-02-29 from its parent group. Conversely, for the quarter closed 2016-02-29 it was $-0.6684.

Basic net EPS

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) basic net EPS was $-0.14 for the year ended 2016-02-29. For the quarter ended 2016-02-29, it came at $-0.14.

Consolidated diluted EPS

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) consolidated diluted EPS was -0.6684 for the year ended 2016-02-29. For the quarter ended 2016-02-29, it stood at $-0.6684.

Basic diluted EPS

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) basic diluted EPS was $-0.1437 for the quarter ended 2016-02-29. For the year ended 2016-02-29, basic diluted EPS was $-0.1437.

Net diluted EPS

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) posted net diluted EPS of $-0.67 for the fiscal closed 2016-02-29. For the quarter ended 2016-02-29, net diluted EPS was $-0.67.

Diluted EPS from parent

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) diluted EPS from parent group was $-0.6684 for the year ended 2016-02-29. For the quarter ended 2016-02-29 it stood at $-0.6684.

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) net basic EPS was $-0.67 for the year ended 2016-02-29. For the quarter ended 2016-02-29, it was $-0.67.

For the year ended 2016-02-29, basic shares outstanding were 10.821 while for the quarter ended 2016-02-29 is 10.821.

For the fiscal ended 2016-02-29, the diluted outstanding shares were 10.821 and for the quarter ended 2016-02-29 it was 10.821.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 6 times, 1 visits today)